How can we improve platelet preparation and storage?

[1]  J. Bring,et al.  Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets: Comparison between Platelet Concentrates Derived from Pooled Buffy Coates and Apheresis , 1996, Vox sanguinis.

[2]  F. Claas,et al.  Occurrence of Allogeneic HLA and Non-HLA Antibodies After Transfusion of Prestorage Filtered Platelets and Red Blood Cells: A Prospective Study , 1995 .

[3]  R. Stromberg,et al.  In vitro and in vivo effects of prestorage filtration of apheresis platelets , 1995, Transfusion.

[4]  A. Giulivi,et al.  Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage , 1995, Transfusion.

[5]  D. Rhenen,et al.  Evaluation of a new citrate‐acetate‐NaCl platelet additive solution for the storage of white cell‐reduced platelet concentrates obtained from half‐strength CPD pooled buffy coats , 1995, Transfusion.

[6]  Edward J. Lee,et al.  White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group , 1995, Transfusion.

[7]  A. J. Bell.  Peripheral blood stem cell transplants in lymphoma. , 1994, Transfusion science.

[8]  V. Kretschmer,et al.  A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy. , 1994, Transfusion science.

[9]  Yun-Fai Chris Lau,et al.  A prospective study of symptomatic bacteremia following platelet transfusion and of its management , 1994, Transfusion.

[10]  M. Blajchman,et al.  BACTERIAL CONTAMINATION OF CELLULAR BLOOD COMPONENTS , 1994, Vox sanguinis.

[11]  S. Holme.  Platelet storage in a liquid environment. , 1994, Transfusion science.

[12]  L. Corash,et al.  Photochemical inactivation of pathogenic bacteria in human platelet concentrates. , 1994, Blood.

[13]  M. Lundholm,et al.  Novel automated microbial screening of platelet concentrates , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  S. Murphy,et al.  Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate‐containing additive solution , 1993, Transfusion.

[15]  H. Gulliksson.  Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies , 1993, Transfusion.

[16]  S Murphy,et al.  Platelet quality after 15‐day storage of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium , 1992, Transfusion.

[17]  W. Heaton,et al.  Extended Storage of Platelets in an Artificial Medium with the Platelet Activation Inhibitors Prostaglandin E1 and Theophylline 1 , 1991, Vox sanguinis.

[18]  D. Roos,et al.  In vitro Evaluation of Buffy‐Coat‐Derived Platelet Concentrates Stored in a Synthetic Medium 1 , 1991, Vox sanguinis.

[19]  P. Withers,et al.  Alternative Fuels for Platelet Storage: A Metabolic Study , 1990, Vox sanguinis.

[20]  P. Whitley,et al.  Platelet Storage Lesions in Second‐Generation Containers: Correlation with in vivo Behavior with Storage up to 14 Days , 1990, Vox sanguinis.

[21]  T. Gunter,et al.  Mechanisms by which mitochondria transport calcium. , 1990, The American journal of physiology.

[22]  Riitta Kekomäki,et al.  Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components , 1990 .

[23]  D. Riccardi,et al.  Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium , 1989, Transfusion.

[24]  J. Hansen,et al.  Centrifugation of Very Freshly Donated Blood May Yield Platelets Unstable to Storage in the New Generation of Containers , 1989, Vox sanguinis.

[25]  S. Murphy,et al.  Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion , 1987, Transfusion.

[26]  G. Rock,et al.  Platelet storage in a plasma‐free medium , 1985, Transfusion.

[27]  J. Fratantoni,et al.  Aberrant morphology of platelets stored in five day containers. , 1984, Thrombosis research.

[28]  R. Kahn,et al.  Improved storage of platelets for transfusion in a new container. , 1982, Blood.

[29]  R. Aster,et al.  Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. , 1978, The Journal of laboratory and clinical medicine.

[30]  J. Bring,et al.  Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets , 1996 .

[31]  C. Högman,et al.  Buffy-Coat-Derived Platelet Concentrates Prepared from Half-Strength Citrate CPD and CPD Whole-Blood Units , 1995 .

[32]  K. Pflüger,et al.  Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution , 1993 .

[33]  S. Holme.  Effect of additive solutions on platelet biochemistry. , 1992, Blood cells.

[34]  Bode Ap.  Platelet activation may explain the storage lesion in platelet concentrates. , 1990 .

[35]  C. Prowse.  Donation Procedure: Collection Lesion, Fibrinopeptide A, and Factor VIII , 1985 .

[36]  C. S. Sibinga,et al.  Plasma Fractionation and Blood Transfusion , 1985, Developments in Hematology and Immunology.